Chest Wall Perforator Flaps in Breast Cancer Surgery: A Systematic Review of Clinical Outcomes, Complications, and Patient‐Reported Satisfaction
World Journal of Surgery · 2026
DOI: 10.1002/wjs.70393 ↗At a glance
Systematische Übersicht in World Journal of Surgery, 2026. Written by Sanjay K Yadav and 5 co-authors. Institution: Department of Surgery, NSCB Medical College, Jabalpur, India. Major MEDLINE topics: Perforator Flap, Breast Neoplasms, Thoracic Wall, Patient Satisfaction. Cited 1 times so far (Crossref); 56 references.
Abstract (original language)
Background
Chest wall perforator flaps (CWPFs) offer a promising, volume‐preserving reconstructive option for patients undergoing breast‐conserving surgery. However, standardized data on safety, efficacy, and patient‐reported outcomes remain limited.
Methods
This systematic review was conducted in accordance with PRISMA guidelines. A comprehensive search of PubMed, Embase, clinical trial registries, and grey literature was performed up to April 2025. Primary outcomes were surgical complications, operative time, and validated patient satisfaction scores. Secondary outcomes included aesthetic assessments and oncologic safety. Methodological quality was assessed using the MINORS criteria. Meta‐analysis was not performed due to heterogeneity.
Results
Fifty‐two studies involving 2591 patients were included. Overall complication rates were low: seroma (5.0%), infection (∼2%), fat necrosis (1.6%), flap loss (0.7%), and wound dehiscence (1.5%). Cosmetic outcomes, when evaluated by patients or surgeons, were generally rated good to excellent. Validated PROMs were underutilized. Oncologic outcomes reported by a minority of studies suggested low locoregional (∼2%) and distant (∼4.3%) recurrence rates, with 5‐year overall survival exceeding 90% in most series.
Conclusion
CWPFs appear to provide favorable aesthetic outcomes with low short‐term morbidity across heterogeneous observational cohorts. However, oncologic outcomes are sparsely reported with short and inconsistent follow‐up and incomplete adjustment for tumor biology, systemic therapy, and radiotherapy. Accordingly, oncologic safety cannot be inferred from the current evidence, and the certainty of evidence for oncologic endpoints is very low. Prospective, standardized studies reporting LRR/DFS/OS at prespecified time‐points and using validated PROMs are essential.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Surgery, NSCB Medical College, Jabalpur, India.
- Oncoplastic Breast Surgeon, Chennai Breast Centre, Chennai, India.
- NSCB Medical College, Jabalpur, India.
- Surgical Oncology, AIIMS, Patna, India.
- Breast and General Surgeon, Malappuram, Kerala, India.
- Department of Breast Oncosurgery, Tata Medical Center, Kolkata, India.
ORCID profiles: Sanjay K Yadav
Cite
APA
Yadav, S. K., S, D., Sethi, S., Azhar, T., Abdurahman, A., & Agrawal, S. K. (2026). Chest Wall Perforator Flaps in Breast Cancer Surgery: A Systematic Review of Clinical Outcomes, Complications, and Patient‐Reported Satisfaction. World Journal of Surgery. https://doi.org/10.1002/wjs.70393
Vancouver
Yadav SK, S D, Sethi S, Azhar T, Abdurahman A, Agrawal SK. Chest Wall Perforator Flaps in Breast Cancer Surgery: A Systematic Review of Clinical Outcomes, Complications, and Patient‐Reported Satisfaction. World Journal of Surgery. 2026. doi:10.1002/wjs.70393
BibTeX
@article{Yadav2026,
author = {Yadav, Sanjay K and S, Debashree and Sethi, Shivank and Azhar, Tashibihul and Abdurahman, Afrah and Agrawal, Sanjit Kumar},
title = {Chest Wall Perforator Flaps in Breast Cancer Surgery: A Systematic Review of Clinical Outcomes, Complications, and Patient‐Reported Satisfaction},
journal = {World Journal of Surgery},
year = {2026},
doi = {10.1002/wjs.70393}
}
EUVIMED